Seroprevalence of and Its Associated Risk Factors Among Women of Reproductive Age in Saudi Arabia: a Systematic Review and Meta-analysis

Overview

Journal Int J Womens Health

Publisher Dove Medical Press

Specialty Gynecology & Obstetrics

Date 2018 Oct 6

PMID 30288126

Citations 7

Authors

Riyadh A Alzaheb

Affiliations

Soon will be listed here.

Abstract

(), which infects many warm-blooded animals including humans, causes toxoplasmosis, a globally widespread condition. To date, no research has explored the overall infection seroprevalence among women in Saudi Arabia, nor have the risk factors associated with the infection been examined in the Saudi Arabian context. The present systematic review and meta-analysis therefore aimed to investigate toxoplasmosis seroprevalence based on previous study samples of Saudi women of reproductive age, and to establish the potentially risk factors in this national context. PubMed, Science Direct, and Scopus were searched for studies on seroprevalence among women in mainland Saudi Arabia published between January 2000 and December 2017. Seroprevalence with 95% CI was presented for each study, and point estimates and their 95% CIs of pooled seroprevalence were then calculated. Twenty papers were eligible for inclusion, with samples totaling 13,597 females of childbearing age (ie, between 15 and 49 years) covering various regions of Saudi Arabia. The pooled estimation for prevalence using a random-effect model was calculated as 27.8% (95% CI =20.6%-36.3%). A significant association was observed between age and seroprevalence. This review represents the first comprehensive and systematic evaluation of infection seroprevalence among Saudi Arabian women, and reports a high prevalence of infection. Further research is required to support the development of more cost-effective preventive strategies.

Citing Articles

Toxoplasmosis Knowledge and Preventive Behaviours Among Pregnant Women in Jeddah, Saudi Arabia: A Cross-Sectional Study.

Alghafari W Healthcare (Basel). 2025; 13(2).

PMID: 39857201 PMC: 11765061. DOI: 10.3390/healthcare13020174.

The Prevalence of Toxoplasma gondii in Saudi Arabia (1994-2023): A Systematic Review and Meta-Analysis.

Moafa H, Altemani A, Alaklabi A, Ghailan K, Alshabi A, Darraj M J Epidemiol Glob Health. 2024; 14(4):1413-1452.

PMID: 39388058 PMC: 11652434. DOI: 10.1007/s44197-024-00314-5.

Seroprevalence and Distribution of Toxoplasma gondii Infections among Patients in the West Bank, Palestine (2017-2021).

Abu Seir R, Behnke J, Abu-Madi M Am J Trop Med Hyg. 2024; 111(5):1000-1004.

PMID: 39288771 PMC: 11542537. DOI: 10.4269/ajtmh.23-0721.

Serosurvey of and spp. co-infection in pregnant women in low-income areas of Brazil.

Pereira E, Ferreira I, Victorino R, Lescano S, Giuffrida R, Kmetiuk L Front Public Health. 2024; 12:1340434.

PMID: 38333736 PMC: 10850292. DOI: 10.3389/fpubh.2024.1340434.

Seroprevalence of infection among babies in Jeddah Province, Saudi Arabia: a retrospective study.

Hassanein R, El-Shemi A, Alkurbi M, Alahmadi A, Almatery W Pan Afr Med J. 2022; 42:72.

PMID: 36034029 PMC: 9379394. DOI: 10.11604/pamj.2022.42.72.32877.

References

Ghazi H, Telmesani A, Mahomed M . TORCH agents in pregnant Saudi women. Med Princ Pract. 2002; 11(4):180-2. DOI: 10.1159/000065813. View

Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A . Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis. 2007; 39(3):231-4. DOI: 10.1080/00365540600978880. View

El-Shahawy I, Khalil M, Bahnass M . Seroprevalence of Toxoplasma gondii in women in Najran City, Saudi Arabia. Saudi Med J. 2014; 35(9):1143-6. View

Robert-Gangneux F, Darde M . Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012; 25(2):264-96. PMC: 3346298. DOI: 10.1128/CMR.05013-11. View

Al-Mohammad H, Amin T, Balaha M, Al-Moghannum M . Toxoplasmosis among the pregnant women attending a Saudi maternity hospital: seroprevalence and possible risk factors. Ann Trop Med Parasitol. 2010; 104(6):493-504. DOI: 10.1179/136485910X12786389891443. View

Pappas G, Roussos N, Falagas M . Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009; 39(12):1385-94. DOI: 10.1016/j.ijpara.2009.04.003. View

Dubey J, Jones J . Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008; 38(11):1257-78. DOI: 10.1016/j.ijpara.2008.03.007. View

Munoz-Zanzi C, Fry P, Lesina B, Hill D . Toxoplasma gondii oocyst-specific antibodies and source of infection. Emerg Infect Dis. 2010; 16(10):1591-3. PMC: 3294384. DOI: 10.3201/eid1610.091674. View

The Lancet Infectious Diseases . Toxoplasma gondii: an unknown quantity. Lancet Infect Dis. 2012; 12(10):737. DOI: 10.1016/S1473-3099(12)70247-5. View

10.

Foroutan-Rad M, Khademvatan S, Majidiani H, Aryamand S, Rahim F, Malehi A . Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis. Acta Trop. 2016; 158:160-169. DOI: 10.1016/j.actatropica.2016.03.003. View

11.

Mwambe B, Mshana S, Kidenya B, Massinde A, Mazigo H, Michael D . Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania. Parasit Vectors. 2013; 6:222. PMC: 3750225. DOI: 10.1186/1756-3305-6-222. View

12.

Almogren A . Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med. 2011; 31(6):569-72. PMC: 3221125. DOI: 10.4103/0256-4947.87090. View

13.

Tenter A, Heckeroth A, Weiss L . Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58. PMC: 3109627. DOI: 10.1016/s0020-7519(00)00124-7. View

14.

Almushait M, Bin Dajem S, Elsherbiny N, Eskandar M, Al Azraqi T, Makhlouf L . Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in south western, Saudi Arabia. J Parasit Dis. 2014; 38(1):4-10. PMC: 3909581. DOI: 10.1007/s12639-012-0195-z. View

15.

Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A . Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014; 137:185-94. DOI: 10.1016/j.actatropica.2014.05.015. View

16.

Flegr J, Prandota J, Sovickova M, Israili Z . Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014; 9(3):e90203. PMC: 3963851. DOI: 10.1371/journal.pone.0090203. View

17.

Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A . Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2014; 8(12):1503-10. DOI: 10.3855/jidc.4796. View

18.

Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A . Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Trop Med Health. 2017; 45:7. PMC: 5389165. DOI: 10.1186/s41182-017-0048-7. View

19.

El Deeb H, Salah-Eldin H, Khodeer S, Allah A . Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia governorate, Egypt. Acta Trop. 2012; 124(3):185-91. DOI: 10.1016/j.actatropica.2012.08.005. View

20.

Alghamdi J, Elamin M, Alhabib S . Prevalence and genotyping of among Saudi pregnant women in Saudi Arabia. Saudi Pharm J. 2016; 24(6):645-651. PMC: 5094437. DOI: 10.1016/j.jsps.2015.05.001. View